GAP Solutions, Inc. ยท 14 hours ago
Biologist (BSL-3)
GAP Solutions, Inc. is seeking a Biologist to provide services in support of the Laboratory of Infectious Diseases within the National Institute of Allergy and Infectious Diseases. The role involves assisting in the development of vaccines and antiviral therapeutics, performing various biological techniques, and maintaining laboratory operations.
Management Consulting
Responsibilities
Assist with the development of next-generation universal influenza and betacoronavirus vaccines, and antiviral therapeutics to treat respiratory disease, including 1918 H1N1, highly pathogenic avian, and zoonotic influenza infections
Use clinical and animal model samples to perform antibody titration and epitope analysis, including hemagglutination inhibition (HAI), neuraminidase inhibition (NAI), and enzyme-linked immunosorbent assay (ELISA), and viral microneutralization assays
Perform high-throughput screening for antiviral drugs and/or vaccine immune correlate studies
Perform molecular biology techniques, including RNA isolation, molecular cloning, and PCR
Perform cell culture, viral stock, and vaccine stock production
Perform work in biosafety level 2 and 3 (BSL-2 and BSL-3) virology laboratory, including use of a personal air purifying respirator (PPAR)
Participation in the NIH Biosurety and Select Agent personnel programs
Perform single cell RNA sequencing (scRNA-seq) using the 10x Genomics platform, including preparing single-cell suspensions
Provide upkeep and routine maintenance for project, maintaining laboratory supplies and equipment including chemicals, biological materials, etc., required to handle biological materials, recombinant protein materials, acids, biological wastes, etc., maintaining work bench and equipment related to projects
Maintain detailed records of experiments and their results and prepare the information resulting from these experiments for presentations at laboratory-wide meetings and for publication
Write reports of findings, stating methods and procedures, including any modifications employed, samples and materials involved and results of experiments. Interpreting, evaluating, and discussing the results of each experiment with the supervisor as part of the planning process for subsequent studies
Operate and communicate effectively in a group, team-oriented working environment. Work with and support others in a collegial, open, respectful, and interactive working manner. Work collaboratively with others in the lab to generate data for publications
Qualification
Required
Bachelor's degree in Biology or related field
Experience in developing vaccines and antiviral therapeutics
Proficiency in antibody titration and epitope analysis techniques, including hemagglutination inhibition (HAI), neuraminidase inhibition (NAI), enzyme-linked immunosorbent assay (ELISA), and viral microneutralization assays
Experience with high-throughput screening for antiviral drugs and/or vaccine immune correlate studies
Knowledge of molecular biology techniques, including RNA isolation, molecular cloning, and PCR
Experience in cell culture, viral stock, and vaccine stock production
Ability to work in biosafety level 2 and 3 (BSL-2 and BSL-3) virology laboratory
Participation in the NIH Biosurety and Select Agent personnel programs
Experience with single cell RNA sequencing (scRNA-seq) using the 10x Genomics platform
Ability to maintain laboratory supplies and equipment
Strong record-keeping skills for experiments and results
Ability to write reports of findings and discuss results with supervisors
Effective communication and teamwork skills
Company
GAP Solutions, Inc.
GAP Solutions, Inc.
H1B Sponsorship
GAP Solutions, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (11)
2024 (16)
2023 (6)
2022 (8)
2021 (6)
Funding
Current Stage
Late StageTotal Funding
unknown2017-12-06Acquired
Recent News
2023-12-21
Company data provided by crunchbase